C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/30 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/44 (2006.01) A61K 31/4409 (2006.01) A61K 31/505 (2006.01) C07D 213/06 (2006.01) C07D 213/26 (2006.01) C07D 213/32 (2006.01) C07D 213/57 (2006.01) C07D 213/61 (2006.01) C07D 213/68 (2006.01) C07D 239/26 (2006.01) C07D 277/24 (2006.01)
Patent
CA 2402288
Use of compounds of the formula (I) where A, E, R1, R2, p and q have the meanings given in the specification are GluR6 antagonists useful for the treatment of disorders of the central nervous system.
L'invention concerne l'utilisation de composés représentés dans la formule (I), dans laquelle A, E, R?1¿, R?2¿, p et q ont la signification décrite dans les caractéristiques techniques. Ces composés consistent en des antagonistes de GluR6 utiles pour le traitement de troubles du système nerveux central.
Baker Stephen Richard
Bleakman David
Lamas-Peteira Carlos
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Naphtalene derivatives and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphtalene derivatives and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphtalene derivatives and their pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1356746